Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 13

1170P - Survival outcome prediction of primary melanoma tumours from histology images using deep learning

Date

21 Oct 2023

Session

Poster session 13

Topics

Cancer Intelligence (eHealth, Telehealth Technology, BIG Data)

Tumour Site

Melanoma

Presenters

Céline Bossard

Citation

Annals of Oncology (2023) 34 (suppl_2): S651-S700. 10.1016/S0923-7534(23)01941-5

Authors

C. Bossard1, Y. Salhi2, G. Quereux3, A. Khammari4, S. Salhi2, C. Jérôme1

Author affiliations

  • 1 Pathology, IHP Group, 44000 - Nantes/FR
  • 2 Research, DiaDeep, 69003 - Lyon/FR
  • 3 Dermatology, CHU du Nantes - Hôtel-Dieu, 44093 - Nantes/FR
  • 4 Dermatology, CHU du Nantes - Hôtel-Dieu, 44093 - Nantes, Cedex/FR

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 1170P

Background

Predictive and prognostic biomarkers represent the cornerstone of clinical oncology. Improving the prognostication of melanoma is needed to select patients for effective adjuvant therapies. Taking into account that tumor tissue contains a large amount of clinically relevant hidden information that is not fully exploited, we propose a weakly-supervised deep-learning approach on H&E-stained whole-slide image (WSI) to directly predict survival outcomes in melanoma patients.

Methods

We designed a deep neural (DL) network that extracts features from no-padding patches of WSI (tiles of size 512x512 pixels) using a self-supervised learning framework, which are then fed along with survival information into the DL network assigning a survival risk score to each WSI/patient. The model was trained and validated on 195 cases of primary melanoma diagnosed between 2015 and 2017 originating from the IHP Group and the French RicMel network. Performance was evaluated using cross-validations as well as an external set of 238 cases from the TCGA database. Concordance index (c-index) was used as a metric to assess the performance of the proposed approach.

Results

For the prediction of survival outcomes, the proposed pipeline yielded a c-index of 0.75 and 0.66 for the IHP Group cohort and TCGA dataset respectively. Furthermore, we were able to significantly discriminate the 2 groups of patients, with a good and a poor prognosis in terms of survival with p<0.001 for IHP and p=0.01 for the TCGA based on Kaplan-Meier survival analysis. Our prediction model outperforms the reported scores for the other types of tumours based on deep learning frameworks.

Conclusions

This innovative weakly-supervised deep-learning approach to HE image analysis allows the deep-network to choose its own morphological features, and thus highlights new morphological prognostic biomarkers. Based on this prognostic risk score, we aim to accelerate and improve the clinical decision-making process in the field of melanoma. Due to this exiting result, the performance of our algorithm is challenge on a third independent dataset.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.